SEOUL, South Korean biopharmaceutical firm Celltrion Inc. said Monday its new autoimmune disease treatment, Zymfentra, has made a debut in the U.S. market.

Zymfentra, a subcutaneous injection formulation of Celltrion’s infliximab Remsima, won approv…

Army Region 34, “Suthin” revealed that the drug extraction operation was satisfactory. But there are still leaks. Aiming to use technology to support. “Pol. Col. Thawee” stated that he must adjust his tactics and

SEOUL, The presidential office said Monday it has never used “coercion” against members of the press, apparently responding to controversy over a senior presidential secretary’s intimidating remarks to reporters last week.

Hwang Sang-moo, senior

Bangkok, The Stock Exchange of Thailand reveals 2023 companies listed on the Thai stock market. (The Stock Exchange of Thailand and the Market for Alternative Investment (MAI), 583 companies paid dividends a total of

SEOUL, South Korean stocks opened a tad higher Monday, buoyed by gains in technology stocks.

The benchmark Korea Composite Stock Price Index (KOSPI) added 0.72 point, or 0.03 percent, to 2,667.56 in the first